Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
About this item
Full title
Author / Creator
Publisher
Waltham, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Waltham, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
The cryopyrin-associated periodic syndrome (CAPS) is associated with an overproduction of interleukin-1. Canakinumab, an anti–interleukin-1β monoclonal antibody, was given to 35 patients with CAPS and was found to induce remission in most of the patients.
The cryopyrin-associated periodic syndrome (CAPS) is associated with an overproduction of i...
Alternative Titles
Full title
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_223908940
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_223908940
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa0810787
